Last 38 quarters of trend data · Financial Services · Financial - Credit Services
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -2.97 | — | — | — | — | — | — | — | — | — | — | 2.06 | 2.32 |
| — | — | — | — | — | — | — | — | — | — | — | +1005.5% | — | |
| P/S Ratio | 159.65 | 25.36 | 29.23 | 5.99 | 4.59 | 9.09 | 5.80 | 4.42 | 1.49 | 1.02 | 1.08 | 0.29 | 0.33 |
| — | +179.1% | +404.3% | +35.6% | +207.5% | +789.6% | +435.8% | +1414.3% | +355.3% | -0.7% | +30.6% | -98.9% | -98.2% | |
| P/B Ratio | 2.04 | 2.00 | 2.30 | 0.41 | 0.32 | 0.20 | 0.13 | 1.48 | 0.50 | 0.31 | 0.32 | 0.70 | 0.78 |
| — | +900.6% | +1707.7% | -72.0% | -36.6% | -34.8% | -60.7% | +112.6% | -36.1% | -66.4% | -60.4% | +8.0% | +67.8% | |
| P/FCF | 2306.83 | 33.16 | 38.22 | — | — | 12.46 | 7.95 | 16.30 | 5.50 | — | — | — | — |
| — | +166.1% | +380.7% | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Akso Health Group's operating margin was -2113.4% in Q4 2025, down 0.0 pp QoQ and down 1697.6 pp YoY. The trailing four-quarter average of -1060.6% exceeds the current quarter, suggesting the latest result may reflect seasonal weakness or a one-off headwind. Gross margin contracted 210.4% YoY, suggesting cost inflation or competitive pricing pressure.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -1.9% | -6.0% | -6.0% | 2.8% | 2.8% | 5.5% | 5.5% | 4.3% | 4.3% | 10.8% | 10.8% | 9.5% | 9.5% |
| — | -210.4% | -210.4% | -36.0% | -36.0% | -49.3% | -49.3% | -54.2% | -54.2% | -100.0% | -89.2% | +102.0% | -90.5% | |
| Operating Margin | -1125.4% | -2113.4% | -2113.4% | -7.8% | -7.8% | -415.7% | -415.7% | -259.2% | -259.2% | -1060.5% | -1060.5% | -1.9% | -1.9% |
| — | -408.4% | -408.4% | +97.0% | +97.0% | +60.8% | +60.8% | -13857.6% | -13857.6% | -241.5% | -785.5% | +100.0% | +99.9% | |
| Net Margin | -913.4% | -1713.4% | -1713.4% | -8.5% | -8.5% | -394.6% | -394.2% | -342.9% | -342.9% | -1119.5% | -1119.5% | 13.8% | 13.8% |
| — | -334.2% | -334.6% | +97.5% | +97.5% | +64.8% | +64.8% | -2593.2% | -2593.2% | -307.1% | -755.7% | -99.9% | +100.4% |
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -80.0% | -33.7% | -33.6% | -0.1% | -0.2% | -2.2% | -4.2% | -28.7% | -21.6% | -83.9% | -79.0% | 8.2% | 7.3% |
| — | -1456.5% | -706.1% | +99.5% | +99.2% | +97.4% | +94.7% | -450.0% | -394.6% | -170.0% | -217.0% | -90.5% | +130.3% | |
| ROA | -75.6% | -31.3% | -31.4% | -0.1% | -0.2% | -2.1% | -3.8% | -9.1% | -8.2% | -36.2% | -35.8% | 3.9% | 1.9% |
| — | -1379.6% | -732.5% | +98.5% | +98.0% | +94.2% | +89.5% | -332.7% | -521.2% | -254.7% | -330.6% | -92.5% | +114.0% | |
| ROIC | -73.9% | -31.0% | -30.6% | -0.1% | -0.1% | -1.7% | -3.2% | -8.3% | -7.2% | -38.5% | -37.0% | -0.6% | -0.5% |
| — | -1725.7% | -842.1% | +98.8% | +98.4% | +95.6% | +91.2% | -1376.4% | -1286.2% | -177.7% | -437.1% | +97.4% | +94.8% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
The current ratio has weakened 64.1% YoY to 14.20x, tightening the short-term liquidity position. Debt/Equity has declined for 3 consecutive quarters, reflecting a deleveraging trend.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.00 | 0.00 | 0.01 | 0.02 | 0.02 | — | 0.01 | 0.07 | 1.88 | — | 1.10 | — | 0.98 |
| — | — | -27.7% | -63.9% | -98.7% | — | -98.7% | — | +93.0% | — | -63.8% | — | +58.9% | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 14.20 | 14.20 | 14.20 | 8.19 | 8.19 | 39.52 | 39.52 | 1.46 | 1.46 | 1.76 | 1.76 | 1.90 | 1.90 |
| — | -64.1% | -64.1% | +460.4% | +460.4% | +2144.4% | +2144.4% | -23.1% | -23.1% | +42.0% | +41.6% | +10.5% | +10.5% | |
| Quick Ratio | 14.20 | 14.20 | 14.20 | 8.19 | 8.19 | 39.52 | 39.52 | 1.46 | 1.46 | 1.76 | 1.76 | 1.90 | 1.90 |
| — | -64.1% | -64.1% | +460.4% | +460.4% | +2144.4% | +2144.4% | -23.1% | -23.1% | +42.0% | +41.6% | +10.5% | +10.5% | |
| Interest Coverage | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 38 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare performance and metrics against top competitors.
Start ComparisonAkso Health Group's current P/E is -3.0x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Akso Health Group's current operating margin is -1125.4%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Akso Health Group's business trajectory between earnings reports.